The travel vaccines market in Europe is expected to grow from US$ 995.47 million in 2021 to US$ 1,885.56 million by 2028; it is estimated to grow at a CAGR of 9.6% from 2021 to 2028.
Hepatitis, HIV/AIDS, human papillomavirus (HPV), meningococcal disease, typhoid, and yellow fever are among the various chronic diseases detected across the region. Similarly, in 2021, the Centers for Disease Control and Prevention (CDC) launched the global immunization strategic framework 2021–2030. The framework provides a plan to vaccinate against vaccine-preventable diseases (VPDs), such as hepatitis A and B. Moreover, there are different vaccine routines for travelers proposed by WHO to prevent the spread of deadly infectious diseases. The vaccine routine includes routine vaccines for review before traveling, vaccines for certain destinations, and vaccines demanded by certain countries. In most cases, booster doses of routine vaccines are required if people have not followed the regular schedule. Such initiatives by WHO and CDC enhance the vaccine demand, thereby driving its market growth. On the other hand, the COVID–19 outbreak threatened public health. Various emergency actions were initiated during the pandemic, of which the COVAX initiative was aggressively enacted. Vaccination against COVID–19 was mandatory for people worldwide. Governments in every region mandated vaccines for people traveling within and outside countries. The COVID-19 pandemic contributed significantly to travel vaccines. Thus, the factors mentioned above are driving the market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe travel vaccines market . The Europe travel vaccines market is expected to grow at a good CAGR during the forecast period.
Europe Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Europe Travel Vaccines Market Segmentation
Europe travel vaccines market is segmented into product, application, and country. The Europe travel vaccines market, by product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market. The Europe travel vaccines market, by application, is segmented into domestic travel and outbound travel. In 2021, the outbound travel segment held the largest share of the market. Based on country, the Europe travel vaccines market is segmented into France, Germany, Italy, the UK, Russia, and the Rest of Europe.
Abbott; Dynavax Technologies; Emergent BioSolutions Inc.; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Sanofi; and Valneva SE are among the leading companies in the travel vaccines market in the region.
Others Segment to Dominate Europe Travel Vaccines Market during 2020–2028
According to a new market research study on “Europe Travel Vaccines Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product and Application ” is expected to reach US$ 1,885.56 million by 2028 from 995.47 US$ million in 2021. The market is estimated to grow at a CAGR of 9.6% from 2021 to 2028. The report provides trends prevailing in the Europe travel vaccines market along with the drivers and restraints pertaining to the market growth. Rising incidences of infectious diseases is the major factor driving the growth of the Europe travel vaccines market. However, issues associated with travel vaccines being costly the growth of Europe travel vaccines market.
Europe travel vaccines market is segmented into product, application, and country. The Europe travel vaccines market, by product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market. The Europe travel vaccines market, by application, is segmented into domestic travel and outbound travel. In 2021, the outbound travel segment held the largest share of the market. Based on country, the Europe travel vaccines market is segmented into France, Germany, Italy, UK, Russia, and the Rest of Europe.
Abbott; Dynavax Technologies; Emergent BioSolutions Inc.; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Sanofi; and Valneva SE. are among the leading companies in the Europe travel vaccines market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, GlaxoSmithKline plc and Vir Biotechnology, Inc. had signed a binding agreement to expand their existing collaboration to include the research and development of new therapies for influenza and other respiratory viruses.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Travel Vaccines Market – By Product
1.3.2 Europe Travel Vaccines Market – By Application
1.3.3 Europe Travel Vaccines Market – By Country
2. Europe Travel Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Travel Vaccines Market– Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert Opinion
5. Europe Travel Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Significant Rise in Travel and Tourism
5.1.2 Growing Incidences of Infectious Diseases
5.2 Market Restraints
5.2.1 High Cost of Travel Vaccines
5.3 Market Opportunities
5.3.1 Awareness Regarding Vaccines
5.4 Future Trends
5.4.1 Significant Demand for Vaccines
5.5 Impact Analysis
6. Travel Vaccines Market – Europe Analysis
6.1 Europe Travel Vaccines Marker Revenue Forecast and Analysis
7. Europe Travel Vaccines Market Analysis – By Product
7.1 Overview
7.2 Europe Travel Vaccines Market Revenue Share, by Product (2021 and 2028)
7.3 Hepatitis A
7.3.1 Overview
7.3.2 Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Hepatitis B
7.4.1 Overview
7.4.2 Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
7.5 Meningococcal Vaccines
7.5.1 Overview
7.5.2 Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
8. Europe Travel Vaccines Market Analysis – By Application
8.1 Overview
8.2 Europe Travel Vaccines Market Revenue Share, by Application (2021 and 2028)
8.3 Domestic Travel
8.3.1 Overview
8.3.2 Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Outbound Travel
8.4.1 Overview
8.4.2 Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
9. Europe Travel Vaccines Market – Country Analysis
9.1 Overview
9.1.1 Europe: Travel Vaccines Market, by Country, 2020 & 2028 (%)
9.1.1.1 UK: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.1.1 UK: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.1.2 UK: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.1.3 UK: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
9.1.1.2 Germany: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.2.1 Germany: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.2.2 Germany: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.2.3 Germany: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
9.1.1.3 France: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.3.1 France: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.3.2 France: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.3.3 France: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
9.1.1.4 Italy: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.4.1 Italy: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.4.2 Italy: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.4.3 Italy: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
9.1.1.5 Spain: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.5.1 Spain: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.5.2 Spain: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.5.3 Spain: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
9.1.1.6 Rest of Europe: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.6.1 Rest of Europe: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.6.2 Rest of Europe: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.6.3 Rest of Europe: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
10. Travel Vaccines Market–Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Travel Vaccines Market, (%)
10.3 Organic Developments
10.3.1 Overview
10.4 Inorganic Developments
10.4.1 Overview
11. Company Profiles
11.1 GlaxoSmithKline plc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Merck & Co., Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Sanofi
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Novartis AG
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Pfizer Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Dynavax Technologies
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Emergent BioSolutions Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Abbott
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Valneva SE.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of Terms
LIST OF TABLES.
Table 1. UK: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 2. UK: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 3. Germany: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 4. Germany: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. France: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. France: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. Italy: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 8. Italy: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 9. Spain: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 10. Spain: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 11. Rest of Europe: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 12. Rest of Europe: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 13. Organic Developments Done by Companies
Table 14. Inorganic Developments Done by Companies
Table 15. Glossary of Terms, Europe Travel vaccines Market
LIST OF FIGURES.
Figure 1. Europe Travel Vaccines Market Segmentation
Figure 2. Europe Travel Vaccines Market – By Country
Figure 3. Europe Travel Vaccines Market Overview
Figure 4. Europe Outbound Segment Held Largest Share of Travel Vaccines Market by Product
Figure 5. France to Show Significant Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Expert Opinion
Figure 8. Europe Travel Vaccines Market Impact Analysis of Drivers and Restraints
Figure 9. Europe Travel Vaccines Market – Revenue Forecast and Analysis – 2021- 2028
Figure 10. Europe Travel Vaccines Market Revenue Share, by Product (2021 and 2028)
Figure 11. Europe Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Europe Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Travel Vaccines Market Revenue Share, by Application (2021 and 2028)
Figure 16. Europe Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe: Travel Vaccines Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 19. Europe: Travel Vaccines Market, by Country, 2020 & 2028 (%)
Figure 20. UK: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 21. Germany: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 22. France: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 23. Italy: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 24. Spain: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 25. Rest of Europe: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 26. Growth Strategies in the Travel Vaccines Market, (%)
